ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,134,000 | -99.9% | 895,000 | +32.6% | 2.13% | +45.4% |
| Q3 2016 | $9,240,750,000 | +199959.5% | 675,000 | +8.0% | 1.47% | +79.0% |
| Q2 2016 | $4,619,000 | +20.5% | 625,000 | +4.2% | 0.82% | +7.8% |
| Q1 2016 | $3,834,000 | +42.6% | 600,000 | +39.5% | 0.76% | +87.4% |
| Q4 2015 | $2,688,000 | +7.0% | 430,000 | 0.0% | 0.41% | +1.5% |
| Q3 2015 | $2,511,000 | -32.5% | 430,000 | -4.4% | 0.40% | -10.5% |
| Q2 2015 | $3,722,000 | +16.7% | 450,000 | +16.3% | 0.45% | -16.9% |
| Q1 2015 | $3,189,000 | +16.9% | 387,000 | -2.5% | 0.54% | -31.9% |
| Q4 2014 | $2,727,000 | +19.4% | 397,000 | -6.1% | 0.79% | +18.1% |
| Q3 2014 | $2,284,000 | -8.1% | 423,000 | +8.5% | 0.67% | -9.2% |
| Q2 2014 | $2,484,000 | +29.6% | 390,000 | +64.0% | 0.74% | +28.2% |
| Q1 2014 | $1,917,000 | -59.8% | 237,810 | -66.0% | 0.58% | -69.2% |
| Q4 2013 | $4,774,000 | – | 700,000 | – | 1.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |